This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comAttendees and panelists unpacked recent Executive Orders (EOs) in US legal responses and considered future implications for the life sciences sector. CRA’s...
This CRA Insights shows how research by Joshua Gottlieb and Avi Zenilman reflects market conditions for travel nurses during the COVID-19 pandemic and...
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...
Several CRA economists will be speaking at the conference. Wednesday, April 2 at 10:45am: Renée Duplantis is a moderator on “Can antitrust fix the wage gap?”...
